Skip to main content
Earnings Labs
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI)

NASDAQ·Healthcare·Biotechnology

$1.15

-3.75%

Mkt Cap $243.98M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (3 analysts)

$4.50

Range $2.00 – $7.00

Implied Upside

+291.3%

Consensus $4.50 vs current $1.15